Liv Williamsen

Phenomix Sciences, Inc. develops data-driven precision medicine that individualizes obesity treatment. The company is based in Menlo Park, CA. The company was founded by Andres Acosta and Michael Camilleri. The CEO is Mark N. K. Bagnall.

Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ.

Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN.

Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands.

XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT.

Gila Therapeutics, Inc. provides developing therapies for obesity patients. The company was founded by Sergei Zolotukhin and Andres Acosta in January 2014 and is headquartered in Excelsior, MN.